Safety of MRI Compatible Hardware for MRI-based Image Guidance During Spine Surgery
NCT ID: NCT04563806
Last Updated: 2022-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
EARLY_PHASE1
16 participants
INTERVENTIONAL
2019-04-18
2022-05-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
NCT02387905
Spine Oncology Registry
NCT07225491
Stereotactic Radiosurgery in Metastatic Spinal Cord Compression
NCT02167633
Use of Spinal Sealant System During Spinal Surgery
NCT00458354
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
NCT05023772
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To document the safety of utilizing MRI compatible hardware for intraoperative MRI-based image guidance to perform percutaneous spinal procedures.
SECONDARY OBJECTIVE:
I. To determine the accuracy of the MRI-based image guidance.
OUTLINE:
Patients undergo standard of care spine surgery with MRI-based image guidance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Device feasibility (MRI-guided surgery)
Patients undergo standard of care spine surgery with MRI-based image guidance.
Magnetic Resonance Imaging
Undergo MRI-guided surgery
Therapeutic Conventional Surgery
Undergo spinal surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic Resonance Imaging
Undergo MRI-guided surgery
Therapeutic Conventional Surgery
Undergo spinal surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years old. (The indication for this technique is controversial in skeletally immature patients.)
* All diagnoses are eligible
* Vertebral body site to be treated located from T2 to T12
* Signed informed consent
Exclusion Criteria
* Unable to tolerate general anesthesia and prone position
* Unable to undergo MRI scan of the spine
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudio E Tatsui
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2020-03700
Identifier Type: REGISTRY
Identifier Source: secondary_id
2017-0663
Identifier Type: OTHER
Identifier Source: secondary_id
2017-0663
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.